查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1435180

驅蟲藥市場：按藥物類別、給藥途徑、目標病原體、應用、分銷管道 - 全球預測 2024-2030

Anthelmintic Drugs Market by Drug Class (Benzimidazoles, Piperazine), Route of Administration (Injectable, Oral), Target Pathogen, Application, Distribution Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年抗寄生蟲藥物市場規模為33億美元，預計2024年將達35.7億美元，2030年將達56.8億美元，複合年成長率為8.02%。

全球驅蟲藥市場

主要市場統計
基準年[2023] 33億美元
預測年份 [2024] 35.7億美元
預測年份 [2030] 56.8億美元
複合年成長率（%） 8.02%
驅蟲藥市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估驅蟲藥市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對驅蟲藥物市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場並分析其在成熟細分市場的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-驅蟲藥市場規模及預測是多少？

2-抗寄生蟲藥市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3-驅蟲藥市場的技術趨勢和法律規範是什麼？

4-驅蟲藥市場主要供應商的市場佔有率是多少？

5-進入驅蟲藥市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 寵物收養的增加以及對動物飼養的興趣日益濃厚

健康

      • 增加動物保健和健康支出
      • 蠕蟲感染疾病的加速傳播
    • 抑制因素
      • 昂貴的抗寄生蟲藥
    • 機會
      • 增加動物保健服務中心
      • 驅蟲藥作為癌症免疫調節劑的出現
    • 任務
      • 人們擔心抗藥性的發展
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章依藥物類別分類的驅蟲藥市場

  • 苯並咪唑酮
  • Piperazine

第7章驅蟲藥市場：依給藥途徑

  • 可注射的
  • 口服

第8章以目標病原體分類的驅蟲藥市場

  • 十二指腸鉤蟲瘤
  • 蚓蛔蟲
  • 蟯蟲
  • 毛三稜

第9章驅蟲藥市場：依應用分類

  • 動物
  • 人類
    • 胃腸道感染疾病
    • 實質神經囊蟲病

第10章驅蟲藥市場：依通路分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房
  • 獸醫醫院和診所
  • 動物藥房

第11章美洲驅蟲藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太驅蟲藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲/中東/非洲驅蟲藥市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第15章競爭組合

  • 主要公司簡介
    • Aden Healthcare
    • Anikem Laboratories
    • Bayer AG
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Cipla Limited
    • Dechra Pharmaceuticals PLC
    • Dr.Reddys Laboratories Inc.
    • Edenbridge Pharmaceuticals LLC
    • GlaxoSmithKline PLC
    • Green Cross Remedies
    • Healthy Life Pharma Private Limited
    • Johnson & Johnson Services, Inc.
    • Kosher Pharmaceuticals
    • Lineage Therapeutics Inc
    • Lupin Limited
    • Mankind Pharma Ltd.
    • McKesson Corporation
    • Merck & Co., Inc.
    • Norbrook Laboratories Limited
    • Novartis AG
    • Sankur Pharmaceuticals Pvt. Ltd
    • Takeda Pharmaceutical Company Limited
    • Virbac SA
  • 主要產品系列

第16章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-FB6C9E792F95

[186 Pages Report] The Anthelmintic Drugs Market size was estimated at USD 3.30 billion in 2023 and expected to reach USD 3.57 billion in 2024, at a CAGR 8.02% to reach USD 5.68 billion by 2030.

Global Anthelmintic Drugs Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.30 billion
Estimated Year [2024] USD 3.57 billion
Forecast Year [2030] USD 5.68 billion
CAGR (%) 8.02%
Anthelmintic Drugs Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anthelmintic Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anthelmintic Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anthelmintic Drugs Market, highlighting leading vendors and their innovative profiles. These include Aden Healthcare, Anikem Laboratories, Bayer AG, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Cipla Limited, Dechra Pharmaceuticals PLC, Dr.Reddys Laboratories Inc., Edenbridge Pharmaceuticals LLC, GlaxoSmithKline PLC, Green Cross Remedies, Healthy Life Pharma Private Limited, Johnson & Johnson Services, Inc., Kosher Pharmaceuticals, Lineage Therapeutics Inc, Lupin Limited, Mankind Pharma Ltd., McKesson Corporation, Merck & Co., Inc., Norbrook Laboratories Limited, Novartis AG, Sankur Pharmaceuticals Pvt. Ltd, Takeda Pharmaceutical Company Limited, and Virbac S.A..

Market Segmentation & Coverage

This research report categorizes the Anthelmintic Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Drug Class
    • Benzimidazoles
    • Piperazine
  • Route of Administration
    • Injectable
    • Oral
  • Target Pathogen
    • Ancylostoma Duodenale
    • Ascaris Lumbricoides
    • Enterobius Vermicularis
    • Trichuris Trichiura
  • Application
    • Animal
    • Human
      • Gastrointestinal Infections
      • Parenchymal Neurocysticercosis
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
    • Veterinary Hospitals & Clinics
    • Veterinary Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Anthelmintic Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anthelmintic Drugs Market?

3. What are the technology trends and regulatory frameworks in the Anthelmintic Drugs Market?

4. What is the market share of the leading vendors in the Anthelmintic Drugs Market?

5. Which modes and strategic moves are suitable for entering the Anthelmintic Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Anthelmintic Drugs Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing pet adoption coupled with rising focus towards maintaining animal

health

      • 5.1.1.2. Increasing spending for animal healthcare and wellness
      • 5.1.1.3. Accelerating prevalence of helminthic infections
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of antiparasitic drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing veterinary healthcare services centers
      • 5.1.3.2. Emergence of anthelmintic drugs as immune modulators in cancer
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns about the development of drug resistance
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Anthelmintic Drugs Market, by Drug Class

  • 6.1. Introduction
  • 6.2. Benzimidazoles
  • 6.3. Piperazine

7. Anthelmintic Drugs Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Oral

8. Anthelmintic Drugs Market, by Target Pathogen

  • 8.1. Introduction
  • 8.2. Ancylostoma Duodenale
  • 8.3. Ascaris Lumbricoides
  • 8.4. Enterobius Vermicularis
  • 8.5. Trichuris Trichiura

9. Anthelmintic Drugs Market, by Application

  • 9.1. Introduction
  • 9.2. Animal
  • 9.3. Human
    • 9.4.1. Gastrointestinal Infections
    • 9.4.2. Parenchymal Neurocysticercosis

10. Anthelmintic Drugs Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Hospital Pharmacies
  • 10.3. Online Pharmacies
  • 10.4. Retail Pharmacies
  • 10.5. Veterinary Hospitals & Clinics
  • 10.6. Veterinary Pharmacies

11. Americas Anthelmintic Drugs Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Anthelmintic Drugs Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Anthelmintic Drugs Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. Aden Healthcare
    • 15.1.2. Anikem Laboratories
    • 15.1.3. Bayer AG
    • 15.1.4. Boehringer Ingelheim International GmbH
    • 15.1.5. Ceva Sante Animale
    • 15.1.6. Cipla Limited
    • 15.1.7. Dechra Pharmaceuticals PLC
    • 15.1.8. Dr.Reddys Laboratories Inc.
    • 15.1.9. Edenbridge Pharmaceuticals LLC
    • 15.1.10. GlaxoSmithKline PLC
    • 15.1.11. Green Cross Remedies
    • 15.1.12. Healthy Life Pharma Private Limited
    • 15.1.13. Johnson & Johnson Services, Inc.
    • 15.1.14. Kosher Pharmaceuticals
    • 15.1.15. Lineage Therapeutics Inc
    • 15.1.16. Lupin Limited
    • 15.1.17. Mankind Pharma Ltd.
    • 15.1.18. McKesson Corporation
    • 15.1.19. Merck & Co., Inc.
    • 15.1.20. Norbrook Laboratories Limited
    • 15.1.21. Novartis AG
    • 15.1.22. Sankur Pharmaceuticals Pvt. Ltd
    • 15.1.23. Takeda Pharmaceutical Company Limited
    • 15.1.24. Virbac S.A.
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ANTHELMINTIC DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTHELMINTIC DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANTHELMINTIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANTHELMINTIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANTHELMINTIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANTHELMINTIC DRUGS MARKET DYNAMICS
  • FIGURE 7. ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 8. ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 10. ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2023 VS 2030 (%)
  • FIGURE 12. ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 16. ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. ANTHELMINTIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 26. ANTHELMINTIC DRUGS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANTHELMINTIC DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANTHELMINTIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 6. ANTHELMINTIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANTHELMINTIC DRUGS MARKET SIZE, BY PIPERAZINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 9. ANTHELMINTIC DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ANTHELMINTIC DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 12. ANTHELMINTIC DRUGS MARKET SIZE, BY ANCYLOSTOMA DUODENALE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANTHELMINTIC DRUGS MARKET SIZE, BY ASCARIS LUMBRICOIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ANTHELMINTIC DRUGS MARKET SIZE, BY ENTEROBIUS VERMICULARIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ANTHELMINTIC DRUGS MARKET SIZE, BY TRICHURIS TRICHIURA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 20. ANTHELMINTIC DRUGS MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ANTHELMINTIC DRUGS MARKET SIZE, BY PARENCHYMAL NEUROCYSTICERCOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. ANTHELMINTIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. ANTHELMINTIC DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. ANTHELMINTIC DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. ANTHELMINTIC DRUGS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. ANTHELMINTIC DRUGS MARKET SIZE, BY VETERINARY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 278. ANTHELMINTIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 279. ANTHELMINTIC DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 280. ANTHELMINTIC DRUGS MARKET LICENSE & PRICING